Reynders McVeigh Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$691K Sell
8,111
-1,182
-13% -$105K 0.03% 109
2025
Q4
$734K Buy
9,293
+729
+9% +$57.2K 0.03% 109
2025
Q3
$685K Sell
8,564
-441
-5% -$37.6K 0.03% 116
2025
Q2
$819K Buy
9,005
+480
+6% +$43.8K 0.04% 112
2025
Q1
$799K Sell
8,525
-175
-2% -$15.7K 0.04% 106
2024
Q4
$791K Sell
8,700
-562
-6% -$53.6K 0.04% 112
2024
Q3
$961K Sell
9,262
-195
-2% -$19.9K 0.05% 101
2024
Q2
$918K Hold
9,457
0.05% 99
2024
Q1
$852K Sell
9,457
-170
-2% -$14.4K 0.05% 102
2023
Q4
$767K Sell
9,627
-831
-8% -$62.5K 0.05% 106
2023
Q3
$744K Sell
10,458
-115
-1% -$8.6K 0.05% 104
2023
Q2
$815K Buy
10,573
+524
+5% +$40.6K 0.05% 106
2023
Q1
$755K Sell
10,049
-760
-7% -$56.5K 0.05% 107
2022
Q4
$852K Sell
10,809
-1,129
-9% -$84.6K 0.06% 101
2022
Q3
$839K Buy
11,938
+58
+0.5% +$4.55K 0.07% 99
2022
Q2
$952K Buy
11,880
+1,304
+12% +$102K 0.07% 100
2022
Q1
$802K Sell
10,576
-95
-0.9% -$7.53K 0.05% 119
2021
Q4
$911K Buy
10,671
+505
+5% +$39.4K 0.05% 121
2021
Q3
$768K Buy
10,166
+328
+3% +$26K 0.05% 124
2021
Q2
$800K Buy
9,838
+115
+1% +$9.4K 0.05% 120
2021
Q1
$766K Sell
9,723
-1,126
-10% -$88.3K 0.05% 124
2020
Q4
$928K Buy
10,849
+11
+0.1% +$910 0.06% 106
2020
Q3
$836K Buy
10,838
+351
+3% +$26.8K 0.06% 110
2020
Q2
$768K Buy
10,487
+134
+1% +$9.52K 0.07% 116
2020
Q1
$687K Hold
10,353
0.08% 105
2019
Q4
$713K Sell
10,353
-105
-1% -$7.16K 0.07% 131
2019
Q3
$769K Buy
10,458
+700
+7% +$50.8K 0.08% 116
2019
Q2
$699K Hold
9,758
0.08% 120
2019
Q1
$669K Sell
9,758
-425
-4% -$27.5K 0.07% 125
2018
Q4
$606K Sell
10,183
-217
-2% -$13.6K 0.08% 116
2018
Q3
$696K Buy
10,400
+2,480
+31% +$165K 0.08% 120
2018
Q2
$513K Buy
7,920
+2,511
+46% +$164K 0.07% 135
2018
Q1
$388K Buy
5,409
+544
+11% +$39.1K 0.05% 154
2017
Q4
$367K Hold
4,865
0.05% 160
2017
Q3
$354K Sell
4,865
-300
-6% -$21.6K 0.05% 163
2017
Q2
$383K Hold
5,165
0.05% 158
2017
Q1
$378K Hold
5,165
0.05% 163
2016
Q4
$338K Sell
5,165
-100
-2% -$6.86K 0.05% 169
2016
Q3
$390K Buy
5,265
+505
+11% +$37.3K 0.06% 156
2016
Q2
$348K Hold
4,760
0.05% 168
2016
Q1
$336K Buy
4,760
+820
+21% +$54.6K 0.05% 174
2015
Q4
$262K Buy
3,940
+150
+4% +$9.98K 0.04% 174
2015
Q3
$241K Hold
3,790
0.04% 179
2015
Q2
$248K Sell
3,790
-400
-10% -$27.1K 0.04% 182
2015
Q1
$291K Sell
4,190
-75
-2% -$5.18K 0.05% 155
2014
Q4
$295K Sell
4,265
-1,694
-28% -$114K 0.05% 145
2014
Q3
$389K Hold
5,959
0.07% 131
2014
Q2
$406K Hold
5,959
0.09% 125
2014
Q1
$387K Buy
5,959
+350
+6% +$22.1K 0.09% 122
2013
Q4
$366K Hold
5,609
0.09% 125
2013
Q3
$333K Buy
5,609
+2
+0% +$118 0.09% 124
2013
Q2
$321K Buy
+5,607
New +$333K 0.1% 126

Other funds holding CL

Reynders McVeigh Capital Management's CL Position: Q1 2026 in Review

Reynders McVeigh Capital Management reduced its Colgate-Palmolive (CL) stake by 13% in Q1 2026, selling an estimated $105K and leaving 8,111 shares worth $691K. The position accounts for 0.03% of the portfolio, ranked #109.

Reynders McVeigh Capital Management first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $961K in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Reynders McVeigh Capital Management held 8,111 shares of Colgate-Palmolive worth $691K as of Q1 2026.
  • Reynders McVeigh Capital Management sold 1,182 Colgate-Palmolive shares in Q1 2026, an estimated $105K.
  • Colgate-Palmolive made up 0.03% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #109 holding.
  • Reynders McVeigh Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Reynders McVeigh Capital Management's Colgate-Palmolive position peaked at $961K in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.